IU Simon Comprehensive Cancer Center shared a post on LinkedIn:
“Congratulations to the cancer center’s Bryan Schneider, for being named the associate dean for clinical trials at the Indiana University School of Medicine.
In this role, Dr. Schneider will coordinate with IU Launch Accelerator for Biosciences (IU-LAB) leadership to serve as the IU School of Medicine lead for Eli Lilly and Co.-sponsored clinical trials, function as a central liaison with the Clinical Trials Office at the IU Simon Comprehensive Cancer Center, and work to monitor key performance indicators essential to enhancing the school’s clinical trial enterprise.
More posts featuring IU Simon Comprehensive Cancer Center on OncoDaily.